More Than Y100bn Needed To Curb Medical Costs: Health Ministry (Japan)
This article was originally published in PharmAsia News
Japan's ruling coalition is considering such proposals to curb medical costs as freezing a proposed increase in medical costs for the elderly and canceling new expenses to be borne by the disabled. The Health Ministry estimates that such measures would require more than 100 billion yen per year. The coalition may cancel a plan to increase out-of-pocket medical expenses for those aged 70-74 to 20% in April 2008 from the 10% currently required. The ministry estimates that 50 billion yen in new revenue sources would be needed to table the plan and keep the payment requirement at 10%. The legislation would need to be revised during the current extraordinary Diet session in order to freeze payments. Another 40 billion yen could be necessary to put on hold a plan that would require some aged 75 and older to pay medical insurance premiums under a new medical insurance scheme to launch in April. The step would not require a bill to be passed but new ordinances would have to be created. (Click here for more - May Require Paid Subscription
You may also be interested in...
Public Company Edition: Codiak, Kiromic, Aligos and Opthea have fallen below their initial public offering values, while Tarsus and Praxis are trading higher. Also, 5AM, MPM and Cormorant took biotech SPACs public and Evotec led recent non-IPO financings with a €250m private placement.
US, EU and Canadian authorities recently discussed their approaches to rolling reviews of CMC applications for coronavirus vaccines.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.